Company / Gross Profit
IMMUCELL CORP /DE/ Gross Profit History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$7.9M
FY2025
5-year range
$3.9M / $7.9M
FY2021-FY2025
Trend
+105.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit has fluctuated over the past 10 years, ranging from $2M in FY2012 to $8M in FY2025.
Based on SEC 10-K filings.
$8M in FY2025 with a 10-year CAGR of +10.0%.
Improved from $8M to $8M over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +10.0%
Key checks
Key Insights
- In FY2025, gross profit increased 105.2% year-over-year.
- Lowest gross profit in the period was in FY2012.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.9M | +105.2% |
| FY2024 | $3.9M | -49.4% |
| FY2023 | $7.6M | +41.1% |
| FY2017 | $5.4M | -13.3% |
| FY2016 | $6.3M | +104.2% |
| FY2015 | $3.1M | +0.2% |
| FY2014 | $3.1M | +8.5% |
| FY2013 | $2.8M | +22.2% |
| FY2012 | $2.3M | -4.0% |
| FY2011 | $2.4M | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026